The estimated Net Worth of Peter Anevski is at least $123 Million dollars as of 14 July 2023. Mr. Anevski owns over 20,086 units of Progyny Inc stock worth over $23 and over the last 8 years he sold PGNY stock worth over $118,167,308. In addition, he makes $4,521,660 as President und Chief Operating Officer at Progyny Inc.
Peter has made over 70 trades of the Progyny Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 20,086 units of PGNY stock worth $782,350 on 14 July 2023.
The largest trade he's ever made was selling 960,007 units of Progyny Inc stock on 29 October 2019 worth over $11,731,286. On average, Peter trades about 55,740 units every 17 days since 2016. As of 14 July 2023 he still owns at least 1 units of Progyny Inc stock.
You can see the complete history of Mr. Anevski stock trades at the bottom of the page.
Peter Anevski serves as President, Chief Operating Officer of the Company. Mr. Anevski has served as our Chief Financial and Operating Officer since January 2017 and our President since June 2019. Mr. Anevski has extensive experience managing financial functions for public companies. From May 2013 until September 2016, he served as the Executive Vice President and Chief Financial Officer of WebMD. Prior to that, Mr. Anevski served in senior finance and operations roles at WebMD and predecessor companies for 14 years, including as Senior Vice President, Finance. Mr. Anevski received his B.A. in Accounting from Montclair State University.
As the President und Chief Operating Officer of Progyny Inc, the total compensation of Peter Anevski at Progyny Inc is $4,521,660. There are 1 executives at Progyny Inc getting paid more, with David Schlanger having the highest compensation of $4,964,200.
Peter Anevski is 52, he's been the President und Chief Operating Officer of Progyny Inc since 2020. There are 10 older and 5 younger executives at Progyny Inc. The oldest executive at Progyny Inc is Norman Payson, 72, who is the Independent Director.
Peter's mailing address filed with the SEC is C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018.
Over the last 5 years, insiders at Progyny Inc have traded over $949,717,514 worth of Progyny Inc stock and bought 76,923 units worth $999,999 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Plc Gsk und Gp A, Llcbonderman Davidcou.... On average, Progyny Inc executives and independent directors trade stock every 4 days with the average trade being worth of $2,005,422. The most recent stock trade was executed by Michael E Sturmer on 16 July 2024, trading 9,030 units of PGNY stock currently worth $270,900.
progyny is the leading fertility benefits company that combines service, science, technology and data to provide fertility solutions for self-insured employers. progyny’s approach offers members a comprehensive value based treatment plan that is based on the latest medical science and technology. the benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. progyny supports all fertility solutions to include ivf, iui, embryo banking, egg freezing, adoption and surrogacy.
Progyny Inc executives and other stock owners filed with the SEC include: